Burning Rock Biotech Ltd reports results for the quarter ended in June - Earnings Summary

Burning Rock Biotech

31/08/2021 06:42

* Burning Rock Biotech Ltd  BNR.OQ  reported a quarterly
adjusted loss of CNY1.96​​ per share for the quarter ended in
June. The mean expectation of two analysts for the quarter was
for a loss of CNY1.49 per share.
* Revenue rose 18.7% to CNY127.28 million from a year ago; 
analysts expected CNY139.00 million. 
* Burning Rock Biotech Ltd's reported EPS for the quarter was a
loss of CNY1.96​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Burning Rock Biotech Ltd shares had fallen by 32.3% this
quarter and lost 13.7% so far this year.
* The company reported a quarterly loss of CNY203.67 million.
* Wall Street's median 12-month price target for Burning Rock
Biotech Ltd is $39.94 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 31 at 05:41 a.m.  ​All
figures in Chinese yuan renminbi unless otherwise stated